Overview of Dr. Boire
Dr. Adrienne Boire is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. She received her medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 9 years. She is one of 63 doctors at Memorial Sloan Kettering Cancer Center and one of 482 doctors at New York-Presbyterian Hospital who specialize in Neurology. She has more than 70 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2012 - 2014
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2009 - 2012
- University of ChicagoInternship, Internal Medicine, 2008 - 2009
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2008
- Tufts University School of MedicinePh.D., Biochemistry, 2004
- Macalester CollegeB.A., Biology, Cum Laude, 1999
Certifications & Licensure
- NY State Medical License 2011 - 2026
- NJ State Medical License 2022 - 2025
- IL State Medical License 2008 - 2009
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Simches Young Investigator in Neuro-Oncology Award 2017
- Vienna Medical Academy Award 2017
- Damon Runyon Clinical Investigator Award 2017
- Join now to see all
Clinical Trials
- Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors Start of enrollment: 2020 Apr 10
Publications & Presentations
PubMed
- T cells standing at the gates of brain metastasis.Jan Remsik, Adrienne Boire
Immunity. 2024-11-12 - 5 citationsLeptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future ...Jessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, Ayal A Aizer, Tejus A Bale
Neuro-Oncology. 2024-10-03 - Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors.Richard A Hickman, Alexandra M Miller, Bridget M Holle, Justin Jee, Si-Yang Liu
Acta Neuropathologica Communications. 2024-09-17
Journal Articles
- Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal MetastasisMorikawa A, Jordan L, Rozner R, Patil S, Boire A, Pentsova E and AD Seidman, Clin Breast Cancer, 1/1/2016
- Evaluating Cancer of the Central Nervous System through Next-Generation Sequencing of Cerebrospinal FluidPentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A, Lin X, Fleisher M, Grommes C, Meng F, Selcuklu SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M,..., J Clin Oncol, 1/1/2016
- Molecular interactions in the development and treatment of brain metastasesMartinez NM, Boire A and LM DeAngelis, Int J Mol Sci, 1/1/2013
- Join now to see all
Lectures
- Targeting carcinoma-astrocyte gap junctions in brain metastasis.Boston, MA - 1/25/2017
- Microenvironmental contributions to CNS metastasis.Marseille, France - 1/7/2017
- Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis.Zurich, Switzerland - 1/5/2017
- Join now to see all
Press Mentions
- MSK’s 2023 Commencement Celebrates Largest Class in History and Honors Award WinnersMay 19th, 2023
- Markers of Inflammation and Neurodegeneration in CSF Linked to Severe Symptoms in Hospitalized COVID-19 PatientsMarch 18th, 2021
- Scientists Zeroing in on the Cause of 'COVID Brain'March 5th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: